Defining the mandate of tuberculosis research in a postgenomic era

Medical Principles and Practice

Volumn 13, Issue 4, 2004, Pages 177-184

  Chakhaiyar, Prachee ^a   Hasnain, Seyed E ^a,b  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b CDFD   (India)

Author keywords

In silico; Mycobacterium; Tuberculosis

Indexed keywords

BCG VACCINE; DNA VACCINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; GENE SEQUENCE; GENOME; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PROTEOMICS; REVIEW; TUBERCULOSIS;

BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; GENOMICS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; TUBERCULOSIS, PULMONARY;

EID: 3042685442     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078312     Document Type: Review

References (60)

1. Muller A, MacCallum RM, Sternberg MJ: Benchmarking PSI-BLAST in genome annotation. J Mol Biol 1999;293:1257-1271.
2. King RD, Karwath A, Clare A, Dehaspe L: Accurate prediction of protein functional class from sequence in the Mycobacterium tuberculosis and Escherichia coli genomes using data mining. Yeast 2000;17:283-293.
3. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, Mclean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajani MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;11:537-544. Erratum in: Nature 1998;396:190.
4. Camus JC, Pryor MJ, Medigue C, Cole ST: Reannotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 2002;148:2967-2973.
5. McCue LA, McDonough KA, Lawrence CE: Functional classification of cNMP-binding proteins and nucleotide cyclases with implications for novel regulatory pathways in Mycobacterium tuberculosis. Genome Res 2000;10:204-219.
6. Gomez M, Johnson S, Gennaro ML: Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect Immun 2000;68:2323-2327.
7. Sbai H, Mehta A, DeGroot AS: Use of T cell epitopes for vaccine development. Curr Drug Targets Infect Disord 2001;1:303-313.
8. Washio T, Sasayama J, Tomita M: Analysis of complete genomes suggests that many prokaryotes do not rely on hairpin formation in transcription termination. Nucleic Acids Res 1998;26:5456-5463.
9. Unniraman S, Prakash R, Nagaraja V: Alternate paradigm for intrinsic transcription termination in eubacteria. J Biol Chem 2001;276:41850-41855.
10. Brosch R, Gordon SV, Pym A, Eiglmeier K, Garnier T, Cole ST: Comparative genomics of the mycobacteria. Int J Med Microbiol 2000;290:143-152.
11. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honore N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG: Massive gene decay in the leprosy bacillus. Nature 2001;409:1007-1011.
12. Madan Babu M: Did the loss of sigma factors initiate pseudogene accumulation in M. leprae? Trends Microbiol 2003;11:59-61.
13. Brosch R, Gordon SV, Billault A, Garnier T, Eiglmeier K, Soravito C, Barrell BG, Cole ST: Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect Immun 1998;66:2221-2229.
14. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST: Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002;46:709-717.
15. Mustafa AS, Cockle PJ, Shaban F, Hewinson RG, Vordermeier HM: Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin Exp Immunol 2002;130:37-42.
16. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST: Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003;9:533-539.
17. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA, Sherman DR: Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis 2003;187:117-123.
18. Brosch R, Gordon SV, Buchrieser C, Pym AS, Garnier T, Cole ST: Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast 2000;17:111-123.
19. Tazi L, Kreiswirth B, Carriere C, Tibayrenc M: Molecular epidemiology of Mycobacterium tuberculosis and its relevance to the surveillance and control of TB: An e-debate. Infect Genet Evol 2002;2:153-158.
20. Hasnain SE: Molecular epidemiology of infectious diseases: A case for increased surveillance. Bull World Health Organ 2003;81:474.
21. Alland D, Whittam TS, Murray MB, Cave MD, Hazbon MH, Dix K, Kokoris M, Duesterhoeft A, Eisen JA, Fraser CM, Fleischmann RD: Modeling bacterial evolution with comparative-genome-based marker systems: Application to Mycobacterium tuberculosis evolution and pathogenesis. J Bacteriol 2003;185:3392-3399.
22. Siddiqi N, Shamim M, Amin A, Chauhan DS, Das R, Srivastava K, Singh D, Sharma VD, Katoch VM, Sharma SK, Hanief M, Hasnain SE: Typing of drug resistant isolates of Mycobacterium tuberculosis from India using the IS6110 element reveals substantive polymorphism. Infect Genet Evol 2001;1:109-116.
23. Ahmed N, Alam M, Abdul Majeed A, Asad Rahman S, Cataldi A, Cousins D, Hasnain SE: Genome sequence based, comparative analysis of the fluorescent amplified fragment length polymorphisms (FAFLP) of tubercle bacilli from seals provides molecular evidence for a new species within the Mycobacterium tuberculosis complex. Infect Genet Evol 2003;2:193-199.
24. Ahmed N, Caviedes L, Alam M, Rao KR, Sangal V, Sheen P, Gilman RH, Hasnain SE: Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru. J Clin Microbiol 2003;41:1712-1716.
25. Raman LA, Siddiqi N, Shamim M, Deb M, Mehta G, Hasnain SE: Molecular characterization of Mycobacterium abscessus strains isolated from a hospital outbreak. Emerg Infect Dis 2000;6:561-562.
26. Wilson M, DeRisi J, Kristensen HH, Imboden P, Rane S, Brown PO, Schoolnik GK: Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 1999;96:12833-12838.
27. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK: Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci USA 2001;98:7534-7539.
28. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, Schoolnik GK, Sherman DR: Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 2003;48:833-843.
29. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K: Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002;43:717-731.
30. Fisher MA, Plikaytis BB, Shinnick TM: Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J Bacteriol 2002;184:4025-4032.
31. Manganelli R, Voskuil MI, Schoolnik GK, Smith I: The Mycobacterium tuberculosis ECF sigma factor sigmaE: Role in global gene expression and survival in macrophages. Mol Microbiol 2001;41:423-437.
32. Raman S, Song T, Puyang X, Bardarov S, Jacobs WR Jr, Husson RN: The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J Bacteriol 2001;183:6119-6125.
33. Fernandes ND, Wu QL, Kong D, Puyang X, Garg S, Husson RN: A mycobacterial extracytoplasmic sigma factor involved in survival following heat shock and oxidative stress. J Bacteriol 1999;181:4266-4274.
34. Manganelli R, Voskuil MI, Schoolnik GK, Dubnau E, Gomez M, Smith I: Role of the extracytoplasmic-function sigma factor sigma( H) in Mycobacterium tuberculosis global gene expression. Mol Microbiol 2002;45:365-374.
35. Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, Ko C, Carpenter L, Mehrotra J, Manabe YC, Fleischmann RD, Bishai WR: Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci USA 2002;99:8330-8335.
36. Rodriguez GM, Voskuil MI, Gold B, Schoolnik GK, Smith I: ideR, an essential gene in Mycobacterium tuberculosis: Role of IdeR in irondependent gene expression, iron metabolism, and oxidative stress response. Infect Immun 2002;70:3371-3381.
37. Choudhary RK, Mukhopadhyay S, Chakhaiyar P, Sharma N, Murthy KJR, Katoch VM, Hasnain SE: PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response. Infect Immun 2003;71:6338-6343.
38. Feese MD, Ingason BP, Goranson-Siekierke J, Holmes RK, Hol WG: Crystal structure of the iron-dependent regulator from Mycobacterium tuberculosis at 2.0-A resolution reveals the Src homology domain 3-like fold and metal binding function of the third domain. J Biol Chem 2001;276:5959-5966.
39. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs WR Jr, Russell DG: Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000;406:735-738.
40. Sharma V, Sharma S, Hoener zu Bentrup K, McKinney JD, Russell DG, Jacobs WR Jr, Sacchettini JC: Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol 2000;7:663-668.
41. Van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P: Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000;30:3689-3698.
42. Rosenkrands I, Slayden RA, Crawford J, Aagaard C, Barry CE 3rd, Andersen P: Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol 2002;184:3485-3491.
43. Gupta S, Pandit SB, Srinivasan N, Chatterji D: Proteomics analysis of carbon-starved Mycobacterium smegmatis: Induction of Dps-like protein. Protein Eng 2002;15:503-512.
44. Jungblut PR, Muller EC, Mattow J, Kaufmann SH: Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv not predicted by genomics. Infect Immun 2001;69:5905-5907.
45. Covert BA, Spencer JS, Orme IM, Belisle JT: The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis. Proteomics 2001;1:574-586.
46. Abascal F, Valencia A: Clustering of proximal sequence space for the identification of protein families. Bioinformatics 2002;18:908-921.
47. Tekaia F, Gordon SV, Garnier T, Brosch R, Barrell BG, Cole ST: Analysis of the proteome of Mycobacterium tuberculosis in-silico. Tuber Lung Dis 1999;79:329-342.
48. Su WJ: Recent advances in the molecular diagnosis of tuberculosis. J Microbiol Immunol Infect 2002;35:209-214.
49. Gennaro ML: Immunologic diagnosis of tuberculosis. Clin Infect Dis 2000;30(suppl 3):S243-246.
50. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S: Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000;97:13853-13858.
51. Horwitz MA, Harth G: A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 2003;71:1672-1679.
52. Bao L, Chen W, Zhang H, Wang X: Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003;71:1656-1661.
53. Lowrie DB, Tascon RE, Bonato VLD, Lima Valeria MF, Faccioli LH, Stavropoulos E, Colston MJ, Hewinson RG, Moelling K, Silva CL: Therapy of tuberculosis in mice by DNA vaccination. Nature 1999;400:269-271.
54. Taylor JL, Turner OC, Basaraba RJ, Belisle JT, Huygen K, Orme IM: Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect Immun 2003;71:2192-2198.
55. Siddiqi N, Shamim M, Jain NK, Rattan A, Amin A, Katoch VM, Sharma SK, Hasnain SE: Molecular genetic analysis of multi-drug resistance in Indian isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 1998;93:589-594.
56. Siddiqi N, Shamim M, Hussain S, Choudhary RK, Ahmed N, Prachee C, Banerjee S, Savithri GR, Alam M, Pathak N, Amin A, Hanief M, Katoch VM, Sharma SK, Hasnain SE: Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002;46:443-450.
57. Siddiqi N, Das R, Pathak N, Banerjee S, Ahmed N, Katoch VM, Hasnain SE: Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a TAP like efflux pump. Infection 2004; in press.
58. Galperin MY, Koonin E: Searching for drug targets in microbial genomes. Curr Opin Biotechnol 1999;10:571-578.
59. Smith I: Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003;16:463-496.
60. Kendall SC, Warrener P, Vandevanter DR, Sherman DR, Arain TM, Langhorne MH, Anderson SW, Towell JA, Yuan Y, McMurray DN, Kreiswirth BN, Barry CE, Baker WR: A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 2000;405:962-966.